|
|
|
Volumn 26, Issue 5 SUPPL. 16, 1999, Pages 51-61
|
|
Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GEMCITABINE;
IFOSFAMIDE;
NAVELBINE;
PACLITAXEL;
ADULT;
AGED;
ARTICLE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG CYTOTOXICITY;
DRUG EFFICACY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
HYPERGLYCEMIA;
LUNG NON SMALL CELL CANCER;
MAXIMUM PERMISSIBLE DOSE;
META ANALYSIS;
NEUROPATHY;
PRIORITY JOURNAL;
SURVIVAL TIME;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
DEOXYCYTIDINE;
DNA TOPOISOMERASES, TYPE I;
ENZYME INHIBITORS;
ETOPOSIDE;
HUMANS;
IFOSFAMIDE;
LUNG NEOPLASMS;
PACLITAXEL;
VINBLASTINE;
|
|
EID: 0032721841
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (16)
|
|
References (57)
|
